TINDAMAX Drug Patent Profile
✉ Email this page to a colleague
When do Tindamax patents expire, and what generic alternatives are available?
Tindamax is a drug marketed by Mission Pharma and is included in one NDA.
The generic ingredient in TINDAMAX is tinidazole. There are six drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the tinidazole profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Tindamax
A generic version of TINDAMAX was approved as tinidazole by CHARTWELL RX on April 30th, 2012.
Summary for TINDAMAX
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 134 |
| Clinical Trials: | 2 |
| Patent Applications: | 3,933 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for TINDAMAX |
| What excipients (inactive ingredients) are in TINDAMAX? | TINDAMAX excipients list |
| DailyMed Link: | TINDAMAX at DailyMed |
Recent Clinical Trials for TINDAMAX
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Roxane Laboratories | Phase 1 |
| Mission Pharmacal | Early Phase 1 |
| University of Pittsburgh | Early Phase 1 |
Pharmacology for TINDAMAX
| Drug Class | Nitroimidazole Antimicrobial |
Anatomical Therapeutic Chemical (ATC) Classes for TINDAMAX
US Patents and Regulatory Information for TINDAMAX
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mission Pharma | TINDAMAX | tinidazole | TABLET;ORAL | 021618-001 | May 17, 2004 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Mission Pharma | TINDAMAX | tinidazole | TABLET;ORAL | 021618-002 | May 17, 2004 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
